Annovis Bio, Inc.ANVSEarnings & Financial Report
NYSE
NextMar 31, 2026
ANVS Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-7.4M
Net Profit
$-7.3M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.37
Annovis Bio, Inc. Q3 2025 Financial Summary
Annovis Bio, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-7.3M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-7.3M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Annovis Bio, Inc. Annual Revenue by Year
Annovis Bio, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $10.2M | $7.8M | $5.0M | $14.4M | $13.9M | $26.7M | $21.5M | $17.2M |
| Liabilities | $18.0M | $11.2M | $6.8M | $7.3M | $4.6M | $2.7M | $3.1M | $4.0M |
| Equity | $-7.8M | $-3.4M | $-1.8M | $7.1M | $9.3M | $24.1M | $18.3M | $13.2M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-9.4M | $-7.0M | $-3.4M | $-3.2M | $-8.3M | $-8.1M | $-5.1M | $-3.5M |